OBJECTIVES Primary adenosquamous carcinoma (ASC) of the lung is rare. The current
study was a retrospective two-institutional analysis of surgical therapy with respect to the …

Introduction Adenosquamous lung cancer (ASC) is a rare type of NSCLC with poor
prognosis. There is no consensus on the necessity of adjuvant chemotherapy and the …

Lung cancer is an aggressive type of malignancy with a relative 5-year survival rate of
18.1%(2007–2013). On the brighter side, rates for new lung cancer cases have been falling …

Lung cancer is the leading cause of cancerrelated mortality worldwide [1]. Non-small-cell
lung cancers (NSCLC) are most often adenocarcinomas (ADC), and these harbor epidermal …

Lung cancer is the most common cause of cancer death in the world. Before the millennium,
physicians usually classified lung cancer into nonsmall-cell lung cancer (NSCLC) and small …

Cancer is a disease characterized by abnormal growth of cells in an uncontrolled manner.
Certain cancer cells have the potential to invade or spread into surrounding tissues, by a …

Adenosquamous carcinoma of the lung is an uncommon histological variant of non-small
cell lung carcinoma (NSCLC) associated with a poorer prognosis than either …

While shifts in the treatment paradigms for cancer have been altogether infrequent, a
common thread that links many of them is the pairing of an oncogenic driver event with a …

Ideal graft material for regenerative procedures is autogenous bone graft but the major
disadvantage with this graft is the need for a secondary surgical site to procure donor …

In patients with advanced non-small cell lung cancer harboring epidermal growth factor
receptor (EGFR) mutations, the epidermal growth factor receptor-tyrosine kinase inhibitors …